In February, the Food and Drug Administration issued a boxed warning for the gout treatment febuxostat (Uloric, Takeda) citing a risk for cardiovascular disease. It was approved in 2009 for adult patients with gout. Learn more about this and the 2012 treatment guidelines for gout in this slideshow.
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
东方元语
cdercder
yjh123
v0id
xing_xing
张欢馨
OK
dde
Kao
aajhajkahna
学术文献互助
woshi123
pluto
昏睡的蟠桃
松2026
ansteel
行走的荷尔蒙
科研狗
牧青
皖公网安备34019202002308
